Azimut Medical receives funding for the first pilot trial in LTC in Canada.
- Maxime Bolduc
- Jul 21
- 1 min read
Azimut Medical is proud to announce that the trial evaluating 120 Air-Sequr units
in a long-term care hospital (LTC) has received funding from a combined fund of $7.6 million.
The pan-Canadian envisAGE program is supported by MEDTEQ+ and AGE-WELL. Our pilot trial has received additional funding from the Quebec Ministry of Economy, Innovation and Energy (MEIE).
This program promotes innovation and growth and has a significant impact on older adults and caregivers. We are proud to be part of it!
This innovative 18-month pilot trial will evaluate 120 Air-Sequr devices on 45 patients at the CIUSSS du Centre-Sud-de-l'Île-de-Montréal, under the scientific supervision of the Research Centre of the Institut universitaire de gériatrie de Montréal (CRIUGM).